Synthesis and evaluation of (S,S)-N,N′-bis-[3-(2,2′,6,6′-tetramethylbenzhydryloxy)-2-hydroxy-propyl]-ethylenediamine (S2824) analogs with anti-tuberculosis activity

Add time:08/22/2019    Source:sciencedirect.com

In order to identify new and potent candidate drugs to treat tuberculosis, a library of compounds was screened, and (S,S)-N,N′-bis-[3-(2,2′,6,6′-tetramethylbenzhydryloxy)-2-hydroxy-propyl]-ethylenediamine (S2824) was identified as a hit in the screen. This research discusses our efforts to synthesize and test 30 analogs of this hit for activity against Mycobacterium tuberculosis. Two compounds with homopiperazine ring possess high in vitro activity against drug sensitive and resistant M. tuberculosis with MICs 0.78–3.13 μg/mL (or 1.22–4.88 μM).

We also recommend Trading Suppliers and Manufacturers of N-(N-PROPYL)ETHYLENEDIAMINE (cas 111-39-7). Pls Click Website Link as below: cas 111-39-7 suppliers

Prev:Novel thin film composite forward osmosis membrane of enhanced water flux and anti-fouling property with N-[3-(trimethoxysilyl) propyl] ethylenediamine incorporated
Next:Synthesis, crystal structure determination and antimicrobial studies of copper(II) picrate complexes with N,N,N′,N″-tetrakis(2-hydroxyethyl/propyl) ethylenediamine and tris(2-hydroxyethyl)amine)